Greenville, N.C. - Greenville Pathology, an innovator in women's healthcare by introducing a number of new technologies to the region, today announced the implementation of the ThinPrep Imaging System for cervical cancer screening. The ThinPrep Imaging System combines revolutionary imaging technology with human interpretative expertise to improve cervical cancer screening efficiency and diagnostic accuracy, which will further enhance women's health. Greenville Pathology has been offering the ThinPrep Pap Test since February 1, 1999, and is excited to be the first in the area to add the first fully integrated, interactive computer system, approved by the U.S. Food and Drug Administration (FDA), to assist their cytotechnologists and pathologists in the primary screening of ThinPrep Pap Test slides.
"Greenville Pathology is committed to providing our client's patients with the best new technology available to detect disease early, and the ThinPrep Imaging System enables us to accomplish this goal," said Dr. William Ballance, Jr., owner and medical director. "Using the ThinPrep Imaging System offers significant improvements over previous screening technologies. Making this technology the standard in our practice was an excellent decision for us and most importantly our patients."
The introduction of the ThinPrep Imager is just the latest chapter in the practice's long and impressive record of staying ahead of the healthcare curve, both in technology and its unique business structure.
Greenville Pathology is a CAP (College of American Pathologists) accredited facility that provides a full-service laboratory in the specialties of surgical pathology, cytopathology, and molecular pathology, and was the first in the area to provide the ThinPrep Pap Test and subsequently the first to perform Digene Hybrid Capture II HPV testing from the same specimen used for the Pap smear. This test identifies women with high-risk human papillomavirus (HPV), the cause of essentially all cervical cancer.
In addition to the expertise of its physician-owner and cytotechnologists, Greenville Pathology has demonstrated a commitment to maintaining a stringent control on quality and a strong desire to make investments needed to improve service and screening accuracy.
The ThinPrep Imaging System, produced by Cytyc Corporation, a premier medical device company, has enhanced Greenville Pathology's commitment to precision. Using a complex algorithm, the System's computer identifies the most abnormal cells out of a field of approximately 50,000 cells on a Pap smear slide, helping the cytopathologists and cytotechnologists to find abnormalities faster and diagnose quicker. Improved accuracy can lead to earlier detection of precancerous changes, which is the key to preventing cervical cancer, a disease that affects thousands of women each year in the United States and millions throughout the world.
Cytyc and ThinPrep are registered trademarks of Cytyc Corporation.